| Mrs Amber Ellis, FNP-BC | |
|
140 Stollings Ave, Suite 3, Logan, WV 25601-4035 | |
| (304) 752-4594 | |
| Not Available |
| Full Name | Mrs Amber Ellis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 140 Stollings Ave, Logan, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093049983 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 61591 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Logan Regional Medical Center | Logan, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Living Waters Medical Center | 2769711019 | 2 |
News Archive
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.
Current industry practices for large-scale mammalian cell cultures typically employ a standard platform fed-batch process with fixed volume bolus feeding. Although widely used, these processes are unable to respond to actual nutrient consumption demands from the culture, which can result in accumulation of by-products and depletion of certain nutrients.
Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.
Each week KHN reporter Ankita Rao compiles a selection of recently released health policy studies and briefs.
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).
› Verified 7 days ago
| Entity Name | Healthy Habits Wellness Ctr, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659323665 PECOS PAC ID: 3072539790 Enrollment ID: O20051020001114 |
News Archive
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.
Current industry practices for large-scale mammalian cell cultures typically employ a standard platform fed-batch process with fixed volume bolus feeding. Although widely used, these processes are unable to respond to actual nutrient consumption demands from the culture, which can result in accumulation of by-products and depletion of certain nutrients.
Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.
Each week KHN reporter Ankita Rao compiles a selection of recently released health policy studies and briefs.
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).
› Verified 7 days ago
| Entity Name | Living Waters Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114585619 PECOS PAC ID: 2769711019 Enrollment ID: O20190911002098 |
News Archive
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.
Current industry practices for large-scale mammalian cell cultures typically employ a standard platform fed-batch process with fixed volume bolus feeding. Although widely used, these processes are unable to respond to actual nutrient consumption demands from the culture, which can result in accumulation of by-products and depletion of certain nutrients.
Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.
Each week KHN reporter Ankita Rao compiles a selection of recently released health policy studies and briefs.
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amber Ellis, FNP-BC 140 Stollings Ave, Suite 3, Logan, WV 25601-4035 Ph: (304) 752-4594 | Mrs Amber Ellis, FNP-BC 140 Stollings Ave, Suite 3, Logan, WV 25601-4035 Ph: (304) 752-4594 |
News Archive
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.
Current industry practices for large-scale mammalian cell cultures typically employ a standard platform fed-batch process with fixed volume bolus feeding. Although widely used, these processes are unable to respond to actual nutrient consumption demands from the culture, which can result in accumulation of by-products and depletion of certain nutrients.
Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.
Each week KHN reporter Ankita Rao compiles a selection of recently released health policy studies and briefs.
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).
› Verified 7 days ago
Timothy M Reed, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1188 | |
Jenna Marie Hager, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 77 Hospital Dr, Logan, WV 25601 Phone: 304-896-5200 Fax: 304-896-5300 | |
William Ray Watkins Jr., RN, MSN, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 214 Hanging Rock Hwy, Logan, WV 25601 Phone: 304-784-5404 | |
Takara Leeann Muncy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 174 Lmah Center Rd, Logan, WV 25601 Phone: 304-792-7130 Fax: 304-792-7146 | |
Mr. Printess John Lawrence, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Prosperity Lane, Suite 100, Logan, WV 25601 Phone: 304-831-0073 Fax: 304-831-0471 | |
Patsy Eugenie Stoots, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |